Everlywell, a prominent digital health company, has successfully secured $154.7 million in new funding from investors. The company is at the forefront of pioneering the next generation of biomarker intelligence, adeptly combining AI-powered technology with human insight to deliver personalized, actionable health answers. Everlywell's core mission involves transforming complex biomarker data into life-changing insights, achieved through the seamless integration of advanced diagnostics, virtual care, and patient engagement. This comprehensive approach is designed to fundamentally reshape how and where health happens, making this investment a significant endorsement of its innovative model.
Over the past decade, Everlywell has delivered close to 1 billion personalized health insights, transforming care for 60 million people. The company powers hundreds of enterprise partners, including 8 of the top 10 largest health plans in the U.S. Everlywell's customizable remote-based solution addresses critical care gaps, from chronic condition management to preventive screening, and delivers measurable health outcomes at scale. Its operations are backed by a nationwide clinical network, an integrated lab, and an AI-powered platform, enabling seamless, at-home care that meets today's needs.
The newly secured capital will be strategically deployed to accelerate Everlywell's ambitious growth initiatives. The company plans to further scale its advanced AI-powered platform and significantly expand its reach in remote-based healthcare solutions, thereby enhancing its ability to meet today's evolving health needs and lead future advancements in the sector. This substantial funding round is expected to bolster Everlywell's mission to make personalized health insights more accessible and actionable for a broader population, continuing its strong trajectory in the rapidly evolving digital health landscape.
